TY  - JOUR
PY  - 2023//
TI  - Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: a 24-week randomized controlled trial
JO  - Psychiatry and the Clinical Neurosciences
A1  - Kishimoto, Taishiro
A1  - Kinoshita, Shotaro
A1  - Kitazawa, Momoko
A1  - Hishimoto, Akitoyo
A1  - Asami, Takeshi
A1  - Suda, Akira
A1  - Bun, Shogyoku
A1  - Kikuchi, Toshiaki
A1  - Sado, Mitsuhiro
A1  - Takamiya, Akihiro
A1  - Mimura, Masaru
A1  - Sato, Yasunori
A1  - Takemura, Ryo
A1  - Nagashima, Kengo
A1  - Nakamae, Takashi
A1  - Abe, Yoshinari
A1  - Kanazawa, Tetsufumi
A1  - Kawabata, Yasuo
A1  - Tomita, Hiroaki
A1  - Abe, Koichi
A1  - Hongo, Seiji
A1  - Kimura, Hiroshi
A1  - Sato, Aiko
A1  - Kida, Hisashi
A1  - Sakuma, Kei
A1  - Funayama, Michitaka
A1  - Sugiyama, Naoya
A1  - Hino, Kousuke
A1  - Amagai, Toru
A1  - Takamiya, Maki
A1  - Kodama, Hideyuki
A1  - Goto, Kenichi
A1  - Fujiwara, Shuichiro
A1  - Kaiya, Hisanobu
A1  - Nagao, Kiichiro
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - AIM: Live two-way video, easily accessible from home via smartphones and other devices, is becoming a new way of providing psychiatric treatment. However, lack of evidence for real-world clinical setting effectiveness hampers its approval by medical insurance in some countries. Here, we conducted the first large-scale pragmatic, randomized controlled trial to determine the effectiveness of long-term treatment for multiple psychiatric disorders via two-way video using smartphones and other devices, which are currently the primary means of telecommunication. <br><br>METHODS: This randomized controlled trial compared two-way video versus face-to-face treatment for depressive disorder, anxiety disorder, and obsessive-compulsive disorder in the subacute/maintenance phase during a 24-week period. Adult patients with the above-mentioned disorders were allocated to either a two-way video group (≥50% video sessions) or a face-to-face group (100% in-person sessions) and received standard treatment covered by public medical insurance. The primary outcome was the 36-Item Short-Form Health Survey Mental Component Summary (SF-36 MCS) score. Secondary outcomes included all-cause discontinuation, working alliance, adverse events, and the severity rating scales for each disorder. <br><br>RESULTS: A total of 199 patients participated in this study. After 24 weeks of treatment, two-way video treatment was found to be noninferior to face-to-face treatment regarding SF-36 MCS score (48.50 vs 46.68, respectively; p < 0.001). There were no significant differences between the groups regarding most secondary end points, including all-cause discontinuation, treatment efficacy, and satisfaction. <br><br>CONCLUSION: Two-way video treatment using smartphones and other devices, was noninferior to face-to-face treatment in real-world clinical settings. Modern telemedicine, easily accessible from home, can be used as a form of health care.<p />  <p>Language: en</p>
LA  - en
SN  - 1323-1316
UR  - http://dx.doi.org/10.1111/pcn.13618
ID  - ref1
ER  -